ZAGREB (Croatia), November 7 (SeeNews) – Croatian drug maker Pliva, a subsidiary of U.S. Barr Pharmaceuticals, reported on Friday a net loss of 107 million kuna ($19 million/15 million euro) for the first nine months of 2008 versus a net profit of 842.4 million kuna a year earlier.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
